In one study, tumor biopsies derived from patients participating in a trial based on cetuximab plus folinic acid fluorouracile ininotecan (FOLFIRI) in patients with KRAS-WT were analyzed by next generation sequencing. The gene discussed is KRAS; the disease is neoplasm.